InflaRx NV (IFRX)
2.05
-0.05
(-2.38%)
USD |
NASDAQ |
Aug 24, 16:00
2.04
-0.01
(-0.49%)
After-Hours: 20:00
InflaRx EPS Diluted (Quarterly) : -0.1052 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1052 |
| March 31, 2026 | -0.0905 |
| September 30, 2025 | -0.2115 |
| June 30, 2025 | -0.2412 |
| March 31, 2025 | -0.1382 |
| September 30, 2024 | -0.3255 |
| June 30, 2024 | -0.2531 |
| March 31, 2024 | -0.178 |
| December 31, 2023 | -0.2909 |
| September 30, 2023 | -0.1377 |
| June 30, 2023 | -0.1566 |
| March 31, 2023 | -0.2656 |
| December 31, 2022 | -0.1851 |
| September 30, 2022 | -0.1804 |
| June 30, 2022 | 0.0112 |
| March 31, 2022 | -0.3554 |
| December 31, 2021 | -0.3276 |
| September 30, 2021 | -0.3216 |
| June 30, 2021 | -0.4033 |
| March 31, 2021 | -0.2182 |
| December 31, 2020 | -0.3741 |
| September 30, 2020 | -0.2891 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.4222 |
| March 31, 2020 | -0.3475 |
| December 31, 2019 | -0.5787 |
| September 30, 2019 | -0.6205 |
| June 30, 2019 | -0.6609 |
| March 31, 2019 | -0.4302 |
| December 31, 2018 | -0.4516 |
| September 30, 2018 | -0.307 |
| June 30, 2018 | -0.1191 |
| March 31, 2018 | -0.4916 |
| December 31, 2017 | -1.950 |
| September 30, 2017 | -0.6743 |
| June 30, 2017 | -0.728 |
| March 31, 2017 | -0.5732 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.1705 |
| March 31, 2016 | -0.2114 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | -3.799 |
| Immatics NV | -0.5316 |
| Beam Therapeutics, Inc. | -1.176 |
| Kymera Therapeutics, Inc. | -0.6235 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.38M |
| Total Expenses (Quarterly) | 12.38M |
| Enterprise Value | 121.83M |
| Earnings Yield | -31.63% |
| Normalized Earnings Yield | -27.69 |